Cargando…

Identification of prognostic immune-related lncRNA signature predicting the overall survival for colorectal cancer

Long non-coding RNA (lncRNA) is an important regulator of gene expression and serves a fundamental role in immune regulation. The present study aimed to develop a novel immune-related lncRNA signature to assess the prognosis of patients with colorectal cancer (CRC). Transcriptome data and clinical i...

Descripción completa

Detalles Bibliográficos
Autores principales:	Li, Jianxin, Han, Ting, Wang, Xin, Wang, Yinchun, Chen, Xuan, Chen, Wangsheng, Yang, Qingqiang
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Nature Publishing Group UK 2023
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9873726/ https://www.ncbi.nlm.nih.gov/pubmed/36693898 http://dx.doi.org/10.1038/s41598-023-28305-9

Ejemplares similares

Construction of a Novel Immune-Related mRNA Signature to Predict the Prognosis and Immune Characteristics of Human Colorectal Cancer
por: Li, Jianxin, et al.
Publicado: (2022)

H19 may regulate the immune cell infiltration in carcinogenesis of gastric cancer through miR-378a-5p/SERPINH1 signaling
por: Li, Jianxin, et al.
Publicado: (2022)

Identification of an Immune-Related Nine-lncRNA Signature Predictive of Overall Survival in Colon Cancer
por: Lin, Yilin, et al.
Publicado: (2020)

Development and internal validation of a nine-lncRNA prognostic signature for prediction of overall survival in colorectal cancer patients
por: Zhang, Zhiqiao, et al.
Publicado: (2018)

Identification and characterization of the lncRNA signature associated with overall survival in patients with neuroblastoma
por: Yerukala Sathipati, Srinivasulu, et al.
Publicado: (2019)

Identification and Validation of EMT-Related lncRNA Prognostic Signature for Colorectal Cancer
por: Li, Danfeng, et al.
Publicado: (2021)

N6-Methyladenosine-Related lncRNA Signature Predicts the Overall Survival of Colorectal Cancer Patients
por: Song, Wei, et al.
Publicado: (2021)

Identification and Validation of Immune-Related LncRNA Prognostic Signature for Lung Adenocarcinoma
por: Wu, Guomin, et al.
Publicado: (2021)

Identification of the 3-lncRNA Signature as a Prognostic Biomarker for Colorectal Cancer
por: Liu, Shuzhen, et al.
Publicado: (2020)

Identification and validation of immune‐related lncRNA prognostic signatures for melanoma
por: Xiao, Bo, et al.
Publicado: (2021)

An integrated mRNA–lncRNA signature for overall survival prediction in cholangiocarcinoma
por: Xu, Derong, et al.
Publicado: (2023)

Identification and Validation of a Prognostic lncRNA Signature for Hepatocellular Carcinoma
por: Li, Wang, et al.
Publicado: (2020)

Identification of a Novel Glycolysis-Related LncRNA Signature for Predicting Overall Survival in Patients With Bladder Cancer
por: Zheng, Zhenming, et al.
Publicado: (2021)

Identification and validation of a twelve immune infiltration-related lncRNA prognostic signature for bladder cancer
por: Liu, Chen-Qian, et al.
Publicado: (2022)

Identification of Immune-Related lncRNA Prognostic Signature and Molecular Subtypes for Glioblastoma
por: Yu, Wanli, et al.
Publicado: (2021)

Novel m7G-related lncRNA signature for predicting overall survival in patients with gastric cancer
por: Zhao, Bin, et al.
Publicado: (2023)

Identification and validation of an immune-related lncRNAs signature to predict the overall survival of ovarian cancer
por: Li, He, et al.
Publicado: (2022)

Development of a novel five‐lncRNA prognostic signature for predicting overall survival in elderly patients with breast cancer
por: Luo, Yang, et al.
Publicado: (2021)

Six-lncRNA Immune Prognostic Signature for Cervical Cancer
por: Chen, Qian, et al.
Publicado: (2020)

Identification of cuproptosis-related lncRNA prognostic signature for osteosarcoma
por: Liu, Binfeng, et al.
Publicado: (2022)

Identification and validation of a prognostic immune-related lncRNA signature in bladder cancer
por: Zhao, Kai, et al.
Publicado: (2021)

Identification of a cellular senescence-related-lncRNA (SRlncRNA) signature to predict the overall survival of glioma patients and the tumor immune microenvironment
por: Liu, Qing, et al.
Publicado: (2023)

A seven-lncRNA signature predicts overall survival in esophageal squamous cell carcinoma
por: Mao, Yu, et al.
Publicado: (2018)

Identification and Validation of Immune-Related lncRNA Signature as a Prognostic Model for Skin Cutaneous Melanoma
por: Ping, Shuai, et al.
Publicado: (2021)

CDK1 and CDC20 overexpression in patients with colorectal cancer are associated with poor prognosis: evidence from integrated bioinformatics analysis
por: Li, Jianxin, et al.
Publicado: (2020)

Identification of Prognostic Glycolysis-Related lncRNA Signature in Tumor Immune Microenvironment of Hepatocellular Carcinoma
por: Bai, Yang, et al.
Publicado: (2021)

Identification of LncRNA Prognostic Signature Associated With Genomic Instability in Pancreatic Adenocarcinoma
por: Zhu, Jinfeng, et al.
Publicado: (2022)

Identification of a 5-lncRNA signature-based risk scoring system for survival prediction in colorectal cancer
por: Gu, Liqiang, et al.
Publicado: (2018)

Identification and Validation of an Immune-Related lncRNA Signature to Facilitate Survival Prediction in Gastric Cancer
por: Ma, Ensi, et al.
Publicado: (2021)

Identification of Prognostic Signatures for Predicting the Overall Survival of Uveal Melanoma Patients
por: Xue, Meijuan, et al.
Publicado: (2019)

Identification of an Iron Metabolism-Related lncRNA Signature for Predicting Osteosarcoma Survival and Immune Landscape
por: Hong-bin, Shao, et al.
Publicado: (2022)

Construction of a prognostic glycolysis‐related lncRNA signature for patients with colorectal cancer
por: Zhong, Xinyang, et al.
Publicado: (2022)

Identification and characterization of a 25-lncRNA prognostic signature for early recurrence in hepatocellular carcinoma
por: Fu, Yi, et al.
Publicado: (2021)

A Robust 6-lncRNA Prognostic Signature for Predicting the Prognosis of Patients With Colorectal Cancer Metastasis
por: Li, Shuyuan, et al.
Publicado: (2020)

Development of an Immune-Related LncRNA Prognostic Signature for Glioma
por: Cao, Yudong, et al.
Publicado: (2021)

Identification of the 7-lncRNA Signature as a Prognostic Biomarker for Acute Myeloid Leukemia
por: Liu, Chun-yu, et al.
Publicado: (2021)

Identification of m7G-associated lncRNA prognostic signature for predicting the immune status in cutaneous melanoma
por: Rong, Jielin, et al.
Publicado: (2022)

A four-lncRNA risk signature for prognostic prediction of osteosarcoma
por: Liu, Huanlong, et al.
Publicado: (2023)

Identification and validation of a novel cuproptosis-related lncRNA signature for predicting colorectal cancer patients’ survival
por: Liu, Feng, et al.
Publicado: (2023)

Identification of an Autophagy-Related lncRNA Prognostic Signature and Related Tumor Immunity Research in Lung Adenocarcinoma
por: Chen, Hang, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_3fg4dch89j33o646m9j2kl04f1